Ensayos clínicos

Inclusion Criteria:

• First diagnosis of malignant neoplasm (International Classification of Diseases for Oncology [ICD-O] behavior code of "3") in first and continuous remission at the time of enrollment.
• Curative cancer treatment must have included chemotherapy and/or radiation.
  • Note: Childrens Oncology Group (COG) therapeutic trial participation is not required.
• All cancer treatment must have been completed within 3-36 calendar months prior to enrollment .
• Patients must have a life expectancy of > 1 year.
• Self-report of < 420 minutes of moderate-to-vigorous physical activity per week as assessed via the study-specific Physical Activity Worksheet.
  • Note: COG Study Web Page for the Godin-Shephard Leisure Time Physical Activity Questionnaire or link to online calculator.
• Ambulatory and no known medical contraindications to increasing physical activity.
• No known significant physical or cognitive impairment that would prevent use of the electronic devices used for the protocol intervention (e.g., Fitbit, smartphone, tablet, or computer).
• Able to read and write English -All patients and/or their parents or legal guardians must sign a written informed consent.
  • Note: Informed consent may be obtained electronically/online if allowed by local site policy and Institutional Review Board (IRB)/Research Ethics Board (REB) of record.
• All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met.

Exclusion Criteria:

• Post-menarchal female patients who are pregnant or planning to become pregnant in the next year are excluded.
  • Note: Pregnancy status can be established by clinical history with patient.
• Post-menarchal female patients are eligible as long as they agree to use an effective contraceptive method (including abstinence) during study participation.
• Patients with previous hematopoietic stem cell transplant (HSCT).